Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab

Ann Hematol. 2005 Aug;84(8):551-2. doi: 10.1007/s00277-005-1040-6. Epub 2005 Mar 31.

Authors

Soon Thye Lim, Nancy Rubin, Jonathan Said, Alexandra M Levine

PMID: 15800785
DOI: 10.1007/s00277-005-1040-6

No abstract available

Publication types

Letter

MeSH terms

Anti-Retroviral Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Herpesvirus 8, Human / isolation & purification
Humans
Lymphoma / drug therapy*
Lymphoma / pathology
Lymphoma / virology
Lymphoma, AIDS-Related / diagnosis
Lymphoma, AIDS-Related / drug therapy
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy
Male
Middle Aged
Neoplasms, Second Primary / diagnosis
Neoplasms, Second Primary / drug therapy
Pericardial Effusion / pathology
Pleural Effusion, Malignant / diagnosis
Pleural Effusion, Malignant / drug therapy*
Pleural Effusion, Malignant / virology
Remission Induction
Rituximab

Substances

Anti-Retroviral Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Rituximab